Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Baron

Showing results (181-190 of 281) with videos related to

Pageof 29
Sort By:
The Journal of Rheumatology|June 17, 2014
Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial testsMichael Mahler, Minoru Satoh, Marie Hudson, et al.
Clinical Rheumatology|June 5, 2013
Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosisMarie Hudson, Deborah Assayag, Melissa Caron, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of LifeNancy Maltez, Mathieu Puyade, Mianbo Wang, et al.
Rheumatology (Oxford, England)|September 15, 2012
Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblastsXu Shi-wen, Katherine Thompson, Korsa Khan, et al.
The Journal of Investigative Dermatology|June 10, 2011
Loss of PTEN expression by dermal fibroblasts causes skin fibrosisSunil K Parapuram, Xu Shi-wen, Christopher Elliott, et al.
Clinical and Experimental Rheumatology|March 8, 2016
Reasons for non-participation in scleroderma support groupsVanessa C Delisle, Stephanie T Gumuchian, Sandra Pelaez, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survivalMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
Rheumatology (Oxford, England)|June 11, 2021
Oxidative stress-induced senescence mediates inflammatory and fibrotic phenotypes in fibroblasts from systemic sclerosis patientsOzge Kizilay Mancini, Mariana Acevedo, Nesrine Fazez, et al.
ACR Open Rheumatology|September 17, 2025
Limited Utility of Screening Electrocardiograms in Systemic Sclerosis: Data from the Canadian Scleroderma Research GroupSophie Wojcik, Christos Galatas, Alaa Dekis, et al.
The Lancet. Rheumatology|January 26, 2024
Digital ulcers: should debridement be a standard of care in systemic sclerosis?Michael Hughes, Begonya Alcacer-Pitarch, Yannick Allanore, et al.
Pageof 29

Showing results (181-190 of 281) with videos related to

Sort By:
Pageof 29
The Journal of Rheumatology|June 17, 2014
Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial testsMichael Mahler, Minoru Satoh, Marie Hudson, et al.
Clinical Rheumatology|June 5, 2013
Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosisMarie Hudson, Deborah Assayag, Melissa Caron, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of LifeNancy Maltez, Mathieu Puyade, Mianbo Wang, et al.
Rheumatology (Oxford, England)|September 15, 2012
Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblastsXu Shi-wen, Katherine Thompson, Korsa Khan, et al.
The Journal of Investigative Dermatology|June 10, 2011
Loss of PTEN expression by dermal fibroblasts causes skin fibrosisSunil K Parapuram, Xu Shi-wen, Christopher Elliott, et al.
Clinical and Experimental Rheumatology|March 8, 2016
Reasons for non-participation in scleroderma support groupsVanessa C Delisle, Stephanie T Gumuchian, Sandra Pelaez, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survivalMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
Rheumatology (Oxford, England)|June 11, 2021
Oxidative stress-induced senescence mediates inflammatory and fibrotic phenotypes in fibroblasts from systemic sclerosis patientsOzge Kizilay Mancini, Mariana Acevedo, Nesrine Fazez, et al.
ACR Open Rheumatology|September 17, 2025
Limited Utility of Screening Electrocardiograms in Systemic Sclerosis: Data from the Canadian Scleroderma Research GroupSophie Wojcik, Christos Galatas, Alaa Dekis, et al.
The Lancet. Rheumatology|January 26, 2024
Digital ulcers: should debridement be a standard of care in systemic sclerosis?Michael Hughes, Begonya Alcacer-Pitarch, Yannick Allanore, et al.
Pageof 29